MeSH tree: D04.615.562
A new dressing made from plant-based materials can deliver antibiotics directly to wounds during critical early stages of infection, according to researchers from the University of Bath. The study, published in Bioactive ...
Jul 14, 2026
0
10
Move over, Lyme disease—there's another tick-borne disease to worry about in Canada. Anaplasmosis, the second-most common tick-borne disease in the country, can cause a range of health issues, including myocarditis, as a ...
Jul 13, 2026
0
8
An increasing number of Americans are getting—and surviving—cancer. There were more than 18 million cancer survivors in the U.S. in 2025, and the National Cancer Institute estimates that number will grow to 22 million by ...
Jun 18, 2026
0
6
Researchers in the lab of Cancer Center at Illinois (CCIL) member Xing Wang have discovered the influential role of structural chirality, or "handedness," of a DNA nanostructure to dictate cancer cell response to targeted ...
Jun 8, 2026
0
7
Resistance to antimicrobial agents is rising among human infections with Escherichia coli bacteria that produce the Shiga toxin, according to a study analyzing data from nearly 2,000 infections in the United States between ...
Jun 8, 2026
0
6
Syphilis is a sexually transmitted infection caused by the bacteria Treponema pallidum.
May 4, 2026
0
3
A study shows that small doses of the antibiotic minocycline may help treat panic disorder. Experiments conducted at São Paulo State University (UNESP) in mice and at the Federal University of Rio de Janeiro (UFRJ) in humans ...
Apr 30, 2026
0
27
An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests on human-derived tumors in mice. Triple-negative breast cancer lacks three common drug targets, ...
Apr 22, 2026
0
5
Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy ...
Mar 25, 2026
0
6
UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.
Mar 24, 2026
0
5
